Last year, Allegro became part of the CPBT. The new Centre for Animal-Free Biomedical Translation (CPBT) aims to accelerate the transition to animal-free research for safer, more effective and better treatments with less animal suffering over the next ten years. This will result in economic and social benefits: better medicines and less animal testing.
Today, we are happy and proud that the Dutch National Growth Fund invests 124.5 million euros in the transition to animal-free innovation.
Allegro, as part of CPBT, will be committed to researching the effect of biomechanics in combination with hydrogel in osteoarthritis. A specific interest will be in the equine synovial fluid mechanics, as a pivotal model for regulatory studies.
We are very happy to have been part of such a massive fundraise and already look forward to animal-free clinical research.